drug addiction - Nursing Case Study

Pathophysiology

• Primary mechanism: Drug addiction primarily involves the brain's reward system, where substances increase dopamine levels in the mesolimbic pathway. This surge in dopamine reinforces behavior, creating a cycle of reward and craving.

• Secondary mechanism: Neuroadaptation occurs with repeated drug use, leading to changes in neural circuits. The brain compensates by reducing dopamine receptor sensitivity, requiring higher drug doses to achieve the same effect, fostering dependence.

• Key complication: Tolerance and withdrawal symptoms emerge as the brain's chemistry adapts. The user experiences diminished effects from the same dose and negative symptoms without the drug, driving further use to avoid discomfort.

Patient Profile

Demographics:

32-year-old male, construction worker

History:

• Key past medical history: History of alcohol use disorder, depression

• Current medications: Sertraline 50 mg daily

• Allergies: No known drug allergies

Current Presentation:

• Chief complaint: Increasing difficulty managing daily responsibilities due to substance use

• Key symptoms: Insomnia, anxiety, tremors, gastrointestinal discomfort, occasional palpitations

• Vital signs: Blood pressure 142/90 mmHg, heart rate 98 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 95% on room air

Section 1

As the healthcare team conducts the initial assessment, the patient's presentation raises concerns about the severity of his substance use disorder. Physical examination reveals mild tremors in his hands, which increase in intensity when he is anxious. His skin appears slightly diaphoretic, and there is evidence of excoriation on his arms, likely from scratching due to anxiety or possible substance-related skin irritation. The patient's speech is slightly pressured, and he reports feeling "on edge" most of the time. He admits to consuming increasing amounts of alcohol over the past several months and has recently experimented with prescription opioids to manage his anxiety and insomnia.

Laboratory results further complicate the picture, revealing elevated liver enzymes (AST 68 U/L, ALT 75 U/L), indicative of possible liver stress or damage, potentially from chronic alcohol use. A urine toxicology screen returns positive for opioids, confirming his recent use, alongside elevated blood alcohol levels. These findings suggest a dual substance use pattern, exacerbating his symptoms and complicating his withdrawal and treatment plan.

This dual substance use introduces additional layers of complexity in managing his care. The increased liver enzymes suggest hepatic stress, necessitating careful consideration of any pharmacologic interventions to avoid further liver damage. The overlap between alcohol and opioid use heightens the risk of severe withdrawal symptoms, requiring a comprehensive and closely monitored detoxification process. The healthcare team must employ clinical reasoning to prioritize interventions that address both the immediate withdrawal symptoms and the underlying psychological factors driving his substance use. These considerations will guide the allocation of resources and support systems for this patient, setting the stage for his next steps in recovery.

Section 2

As the patient progresses through the initial phase of detoxification, new complications emerge, prompting the healthcare team to reassess their management strategy. Over the next 48 hours, the patient begins to exhibit signs of worsening withdrawal, characterized by increased tremors, intermittent tachycardia with heart rates peaking at 110 beats per minute, and fluctuating blood pressure readings reaching as high as 150/95 mmHg. These symptoms coincide with episodes of heightened anxiety and agitation, suggesting a potential escalation in withdrawal severity.

Further diagnostic evaluations reveal a concerning trend in laboratory results. The patient's liver enzymes continue to rise, with AST now at 85 U/L and ALT at 92 U/L, indicating ongoing hepatic stress. Additionally, a repeat urine toxicology screen still indicates the presence of opioids, suggesting either a more prolonged metabolism of the substances or potential undisclosed continued use. These findings necessitate a nuanced approach to pharmacologic intervention, balancing the need for symptom control with the risk of exacerbating liver damage.

In response to these developments, the healthcare team initiates a revised treatment protocol, incorporating medications such as gabapentin to help manage the patient's anxiety and tremors while minimizing hepatic impact. Simultaneously, the team emphasizes non-pharmacological interventions, including cognitive behavioral therapy sessions aimed at addressing the psychological underpinnings of his substance use. The patient is also closely monitored for any signs of worsening withdrawal or hepatic function, underscoring the need for vigilant assessment and ongoing adjustment of the care plan to support his recovery journey effectively.

Section 3

As the healthcare team continues to monitor the patient, a new complication arises within the next 24 hours. The patient begins to experience episodes of confusion and disorientation, particularly during the evening hours. These cognitive disturbances are concerning, prompting the team to explore potential causes such as hepatic encephalopathy, given the patient's rising liver enzyme levels and ongoing hepatic stress. A quick assessment reveals the patient's ammonia level is elevated at 65 µmol/L, further supporting the likelihood of hepatic involvement in his mental status changes.

In light of these findings, the team decides to adjust the treatment plan. Lactulose is introduced to help reduce ammonia levels and manage the potential hepatic encephalopathy. The patient's fluid and electrolyte status are closely monitored, as he is also at risk for dehydration due to the diuretic effect of lactulose. Concurrently, the medical team collaborates with the nursing staff to ensure that the patient's environment is calm and structured, minimizing stimuli that could exacerbate his confusion or agitation.

Throughout this period, careful observation and ongoing reassessment are pivotal. The nursing team diligently tracks the patient's orientation, response to lactulose, and any changes in his cognitive function. This situation highlights the complexity of managing withdrawal symptoms in the context of compromised liver function, necessitating a balance between aggressive management of withdrawal and cautious support of hepatic health. As the patient's journey continues, these challenges offer an opportunity for the team to refine their clinical reasoning skills and adapt their interventions to best support the patient's recovery trajectory.

Section 4

The nursing team continues to monitor the patient closely, noting his response to the introduction of lactulose. Initially, the patient exhibits mild improvement in cognitive clarity during the day, though periodic confusion persists in the evening. His orientation fluctuates, with moments of lucidity followed by disorientation. Vital signs reveal a slight tachycardia at 102 beats per minute and blood pressure readings fluctuating between 130/85 mmHg and 145/90 mmHg, suggesting underlying stress or discomfort. The patient's ammonia level is reassessed 48 hours after starting lactulose and shows a modest decrease to 55 µmol/L, indicating some therapeutic effect but also the need for continued monitoring and adjustment.

As the team evaluates the patient's fluid status, they observe signs of dehydration, including dry mucous membranes and a decrease in urinary output, now at 25 mL/hour. The serum sodium level is slightly elevated at 148 mmol/L, and the creatinine level is at the upper limit of normal at 1.3 mg/dL, reflecting potential renal stress. Recognizing the diuretic effect of lactulose, the team decides to adjust the fluid management plan to include increased oral hydration and potential intravenous fluid support if necessary. This decision requires careful balancing to avoid exacerbating the patient's hepatic condition while addressing the risk of dehydration.

In this complex clinical scenario, the team considers the potential for new complications, such as electrolyte imbalances or worsening hepatic encephalopathy, and remains vigilant in their assessments. This situation underscores the importance of interdisciplinary collaboration and the need for adaptive clinical reasoning as the patient's condition evolves. The team prepares to reassess the treatment strategy as further lab results and clinical observations become available, ensuring a comprehensive approach to the patient's recovery and stabilization.

Section 5

New Complications

In the days following the adjustment of the fluid management plan, the nursing team observes a concerning shift in the patient's status. The patient begins to exhibit signs of worsening hepatic encephalopathy, with increased periods of confusion and agitation. His speech becomes slurred, and he experiences difficulty concentrating on simple tasks that he previously handled with mild improvement. This regression prompts the team to reassess his medication and fluid regimen, taking into consideration the delicate balance required in managing his hepatic condition.

Further lab results reveal a significant electrolyte imbalance; the patient's potassium level has dropped to 3.0 mmol/L, indicative of hypokalemia, likely exacerbated by the ongoing use of lactulose. Additionally, the patient's ammonia level has risen again to 68 µmol/L, suggesting that the therapeutic effects of lactulose are being undermined by the electrolyte disturbances. Recognizing these complications, the medical team initiates a plan to correct the hypokalemia with oral potassium supplementation and modifies the lactulose dosage to better balance its therapeutic benefits with the patient's current physiological needs.

This development necessitates an interdisciplinary approach, as the team collaborates with the dietitian to optimize the patient's nutritional intake and with the pharmacy to ensure appropriate medication adjustments. The nursing staff remains vigilant in monitoring the patient's neurological status and electrolyte levels, aware that their clinical reasoning and timely interventions are crucial to preventing further deterioration. As the patient's journey progresses, the focus remains on stabilizing his condition while anticipating and mitigating potential complications that may arise.